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Abstract Electroconvulsive therapy (ECT) has signifi-
cant short-term antidepressant effects on drug-resistant
patients with severe major depression. Animal studies have
demonstrated that electroconvulsive seizures produce
potentiation-like synaptic remodeling in both sub-cortical
and frontal cortical circuits. However, the electrophysio-
logical effects of ECT in the human brain are not known. In
this work, we evaluated whether ECT induces a measurable
change in the excitability of frontal cortical circuits in
humans. Electroencephalographic (EEG) potentials evoked
by transcranial magnetic stimulation (TMS) were collected
before and after a course of ECT in eight patients with
severe major depression. Cortical excitability was mea-
sured from the early and local EEG response to TMS.
Clinical assessment confirmed the beneficial effects of
ECT on depressive symptoms at the group level. TMS/
EEG measurements revealed a clear-cut increase of frontal
cortical excitability after ECT as compared to baseline, that
was significant in each and every patient. The present
findings corroborate in humans the idea that ECT may
produce synaptic potentiation, as previously observed in
animal studies. Moreover, results suggest that TMS/EEG
may be employed in depressed patients to monitor longi-
tudinally the electrophysiological effects of different ther-
apeutic neuromodulators, e.g. ECT, repetitive TMS, and
sleep deprivation. To the extent that depression involves an
alteration of frontal cortical excitability, these measure-
ments may be used to guide and evaluate treatment pro-
gression over time at the single-patient level.
Keywords Cortical excitability  ECT  TMS/EEG 
Neuromodulation  Major depression
Introduction
Electroconvulsive therapy (ECT) is generally recom-
mended to drug-resistant patients suffering from severe
major depression, because of its significant short-term
antidepressant effects (Uk ECT Review Group 2003). The
mechanism of action of ECT still needs to be fully char-
acterized, although several hypotheses have been con-
ceived, involving neurotransmitter systems (Yatham et al.
2010), endocrinological pathways (Kunugi et al. 2006), and
neurogenesis (Nibuya et al. 1995; Madsen et al. 2000).
In animals, electroconvulsive seizures (ECS) have sev-
eral effects on synaptic plasticity, gene transcription, and
cell proliferation. ECS induces potentiation-like long-last-
ing synaptic changes (Stewart et al. 1994), increases the
expression of neurotrophins, especially brain-derived neu-
rotrophic factor (BDNF), and thus the activation of their
receptor tyrosine kinase B (TrkB) (Nibuya et al. 1995;
Altar et al. 2004) and stimulates the proliferation of neu-
ronal and glial cells in the frontal cortex and hippocampus
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(Malberg et al. 2000; Madsen et al. 2005; Perera et al.
2007) of rats and nonhuman primates. BDNF/TrkB
receptors promote neuronal function, growth and regener-
ation (Mamounas et al. 1995) and are mainly located at
glutamatergic synapses, where they trigger synaptic
potentiation and serve as activity-dependent modulators of
synaptic plasticity (Mattson 2008; Minichiello 2009). Glial
cells are also involved in the glutamatergic neurotrans-
mitter system, by providing energy to neurons and releas-
ing neurotrophic factors (Ben Achour and Pascual 2010).
On the other hand, clinical studies have associated stress
and depression with atrophy and loss of neurons and
glia, especially in the prefrontal cortex and hippocampus
(Salvadore et al. 2011; Duman and Voleti 2012). An
abnormally reduced expression of BDNF/TrkB has been
observed in the frontal cortex and hippocampus of suicide
patients (Dwivedi et al. 2003). Moreover, depressive
symptoms have been correlated with dysfunction of the
prefrontal cortex (George et al. 1994), particularly con-
cerning its relationship with limbic structures implicated in
the regulation of mood and anxiety (Alexander et al. 1986;
Drevets 2000; Suwa et al. 2012).
The existence of a causal relationship among depres-
sion, plasticity and neurotrophins proposed by previous
literature (Manji et al. 2001; Zarate et al. 2003) has
encouraged to explore the modulation of motor cortex
excitability induced by ECT in humans (Sommer et al.
2002; Chistyakov et al. 2005; Bajbouj et al. 2005, 2006).
The results of these studies are not conclusive, since cor-
tical excitability was found to be either decreased (Sommer
et al. 2002; Bajbouj et al. 2005, 2006) or increased (Chi-
styakov et al. 2005) after treatment as compared to base-
line. However, two of these studies (Sommer et al. 2002;
Bajbouj et al. 2005) referred to single cases and all of them
used the peripheral muscular responses to transcranial
magnetic stimulation (TMS) of the primary motor cortex to
estimate cortical excitability.
Today, a complementary, direct measure of cortical
excitability in humans can be obtained non-invasively by
means of transcranial magnetic stimulation combined
with electroencephalography (TMS/EEG) (Ilmoniemi et al.
1997; Komssi and Ka¨hko¨nen 2006; Ziemann 2011). This
approach allows to directly perturb cortical regions and to
record the immediate electrophysiological responses of the
stimulated neurons. Most important, TMS-evoked potentials
(TEPs) are characterized by high test–retest reproducibility,
provided that stimulation parameters (site, intensity and
angle) are accurately controlled across subsequent sessions
by means of a magnetic resonance (MR)-guided navigation
system (Casarotto et al. 2010). Hence, TMS/EEG has been
successfully applied to detect, at the group level, cortical
excitability changes induced by repetitive TMS (rTMS) in
healthy individuals (Esser et al. 2006; Veniero et al. 2010).
In these cases, the local synaptic potentiation deliberately
induced in the motor cortex by high-frequency rTMS was
measured as an increase of the amplitude of early TMS-
evoked EEG responses between 0 and 80 ms (Esser et al.
2006; Veniero et al. 2010). Similarly, a recent TMS/EEG
study (Huber et al. 2012) has allowed to detect a physio-
logical increase of cortical excitability with time awake, that
became significant at the single-subject level after one night
of sleep deprivation.
In this work, we employ TMS/EEG to study the elec-
trophysiological changes induced by ECT in human corti-
cal circuits. Thus, we measured the changes in the
immediate EEG response to TMS of the frontal cortex
before and after a course of ECT. The aim of this study was
to contribute to the understanding of the electrophysio-
logical mechanisms of ECT in the human brain and to
evaluate novel tools for monitoring and guiding neuro-
modulation protocols for the treatment of depression.
Materials and Methods
The experimental protocol involved two TMS/EEG
recording sessions for each patient, that were performed,
respectively, the day before the first administration of ECT
(pre-ECT) and the day after the last administration of ECT
(post-ECT), early in the afternoon at about 3:00 pm. The
same stimulation parameters were applied to each patient
in both sessions.
Participants
Eight inpatients suffering from Major Depressive Disorder,
as diagnosed according to the DSM-IV criteria, partici-
pated in this study (Table 1). Physical examination, labo-
ratory tests and electrocardiograms were performed at
admission. All patients were referred to ECT because they
were drug-resistant, i.e. showed a lack of improvement to
at least two different treatments with antidepressants, at
adequate dosage and duration ([6 weeks) (Fava 2003). No
patient had received ECT within 6 months prior to study
enrolment. Additional diagnosis on axis I besides major
depression, mental retardation on axis II, history of drug/
alcohol abuse or dependency, and major medical/neuro-
logical disorders were regarded as exclusion criteria. In
addition, patients with medical history of seizures, con-
vulsions, loss of consciousness and traumatic brain injury,
carriers of intracranial metallic objects and/or of cardiac
pace-makers were excluded to prevent potential adverse
effects of TMS. Severity of the current major depression
episode was rated on the 21-item Hamilton Depression
Rating Scale (HDRS) (Hamilton 1960), administered by a
qualified psychiatrist. HDRS was assessed at baseline, after
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each ECT session, and at the end of the whole treatment.
All patients were properly acquainted with the experi-
mental procedures (Mini-Mental State Examination was
always above 26) before signing a written informed con-
sent to participation. Moreover, we explicitly reassured
them about the possibility of interrupting the experiment
upon any unpleasant feeling. The study was approved by
the Local Ethical Committee.
ECT Delivery
ECT was administered twice a week with bilateral elec-
trode placement (spECTrum 5000Q, MECTA, Tualatin,
OR, USA). Two circular flat electrodes (diameter:
5.08 cm) were positioned on both sides of the head with
midpoints approximately 2.54 cm above the center of a
line connecting the tragus and the external canthus. Current
was delivered through trains (duration: 1.39 ± 0.13 s) of
rectangular, constant-current pulses (amplitude: 800 mA)
with alternating polarity (pulse width: 1.41 ± 0.12 ms;
pulse pairs per second: 57.36 ± 7.36 Hz). The dose titra-
tion method for eliciting adequate seizures and other
technical parameters were established according to
(American Psychiatric Association. Task Force on Elec-
troconvulsive Therapy. 2001). Brief general anesthesia was
induced with thiopental (i.v. 5 mg/kg) and succinylcholine
(i.v. 1 mg/kg) for relaxation. In addition, pre-medication
with atropine (i.m. 0.5 mg/kg) was used to reduce the risk
of vagal immediate bradyarrhythmia or asystole. Each
patient was administered a variable number of ECT ses-
sions, according to the individual clinical needs evaluated
by experienced clinicians (Table 2). Each patient was
carefully evaluated by qualified psychiatrists throughout
the whole ECT protocol, in order to monitor the therapeutic
and cognitive effects of treatment. In particular, ECT was
administered until remission of depressive symptoms (at
least 50 % reduction of HDRS score as compared to pre-
ECT assessment) or onset of unwanted side effects per-
taining cognitive functions.
TMS/EEG Recording
TMS was delivered with a Focal Bipulse 8-Coil (mean/
outer winding diameter ca. 50/70 mm, biphasic pulse
shape, pulse length ca. 280 ls, focal area of the stimulation
hot spot 0.68 cm2; Eximia TMS Stimulator, Nexstim Ltd.,
Helsinki, Finland). Stimulation parameters were controlled
by means of a Navigated Brain Stimulation (NBS) system
(Nexstim Ltd., Helsinki, Finland), that employs a 3D
infrared Tracking Position Sensor Unit (Polaris, Northern
Digital Inc., Waterloo, Canada) and integrates T1-weighted
structural MR images recorded from all patients (3.0 tesla
scanner, Intera, Philips Medical Systems, Best, The
Netherlands; 0.9 9 0.9 9 0.8 mm spatial resolution). This
equipment maps in real time the positions of TMS coil and
subject’s head within the reference space of individual MR
images by aligning the fiducials selected on structural
images with the corresponding digitized scalp landmarks
(nasion, left and right tragus). The NBS system (Ruohonen
and Ilmoniemi 1999; Ruohonen and Karhu 2010) allowed
(i) to precisely stimulate a cortical target selected a priori
on individual MR images, (ii) to estimate the electric field
(EF) induced on the cortical surface by TMS pulses, and
(iii) to accurately repeat the same stimulation parameters
between sessions. The induced EF clearly depends on
stimulation intensity, expressed as percentage of the max-
imal stimulator output, on the relative position between
subject’s head and TMS coil, and on the geometrical and
physical properties of head tissues between the stimulator
and the cortical surface. The distribution and intensity
(expressed in V/m) of the intracranial induced EF was
estimated on-line using a locally best-fitting spherical
model of the subjects’ head and brain and taking into
account the exact shape, 3D position and orientation of the
TMS coil. Precise control over stimulation coordinates
across sessions was obtained by means of a virtual aiming
device, that displayed in real time on a screen any deviation
from the desired target greater than 3 mm and therefore
allowed manual adjustments of the stimulator position.
Table 1 Demographic
characteristics
F female, M male, SNRI
serotonin norepinephrine
reuptake inhibitors, TCA















1 F 54 50 No 2 16 TCA,NL
2 M 42 28 No 2 24 TCA
3 F 60 57 No 1 24 TCA
4 M 53 31 Yes 2 36 TCA
5 F 44 15 Yes 3 6 SNRI
6 F 51 35 Yes 2 24 TCA
7 F 61 41 Yes 7 7 SNRI
8 F 51 39 Yes 3 12 SSRI
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The middle-caudal portion of the superior frontal gyrus
close to the midline (near the boundary between Brodmann
areas 6 and 8) was selected as target area. Indeed, the pre-
frontal cortex is maximally involved by current flow during
bilateral ECT (Boylan et al. 2001; Lee et al. 2012) and its
metabolic activity is significantly modulated by treatment
(Nobler et al. 2000; Suwa et al. 2012). Moreover, this tar-
geting ensured maximal distance from cranial muscles,
which are mainly distributed over the lateral surface of the
scalp and whose unwanted activation by TMS would affect
EEG recordings. TMS pulses were delivered to the target
area nearby the mid-sagittal plane: however, since TMS is
not suited to properly stimulate along the longitudinal fis-
sure (Thielscher et al. 2011), the coil was slightly moved
either towards the left or the right side of the head in order to
better deliver TMS pulses on the convexity of the middle-
caudal portion of the superior frontal gyrus, with the current
perpendicular to its main axis (Supplementary Fig. 1S).
Patients were randomly divided into two groups of equal
size for being predominantly stimulated either on the left
(four patients) or right (four patients) hemisphere. This
protocol was applied to obtain a comparable amount of data
from stimulation of both hemispheres in a small group of
patients, in the lack of a priori assumptions about laterality
of the effects of bilateral ECT. Moreover, this approach
allowed to shorten the duration of TMS/EEG sessions, thus
limiting any additional stress to patients. Two patients were
particularly collaborative and therefore agreed to being
stimulated on both hemispheres (Supplementary Fig. 1S).
Excitation threshold has been reported to change with cor-
tical location (Stewart et al. 2001; Boroojerdi et al. 2002;
Gerwig et al. 2003); moreover, we specifically delivered
TMS pulses over the prefrontal cortex. Therefore, we set
stimulation intensity relying on the actual intracranial
induced EF estimated by the NBS system rather than
referring to the minimum stimulator output needed to pro-
duce a reliable electromyographic response (motor thresh-
old; Rossi et al. 2009). In all patients, the maximum EF
induced by TMS on the cortical surface was kept in the
range 90–130 V/m by means of the NBS system (corre-
sponding to 56–75 % of the maximal stimulator output).
Previous works have shown that this stimulation intensity
elicits EEG responses with good signal-to-noise ratio
(Komssi et al. 2007; Rosanova et al. 2009; Casali et al.
2010). The location of the maximum EF induced by TMS
on the cortical surface was labeled TMS hotspot and was
always located within the target area. Inter-stimulus interval
was randomly jittered between 1500 and 1800 ms (equiv-
alent to ca. 0.56–0.67 Hz). This stimulation rate does not
induce significant reorganization/plasticity processes that
might possibly either affect EEG responses to TMS or
interfere with the longitudinal measurements (Casarotto
et al. 2010). During TMS stimulation, patients wore inserted
earplugs continuously playing a masking noise that abol-
ished the auditory potentials elicited by TMS-associated
clicks (Massimini et al. 2005).
A 60-channel TMS-compatible EEG amplifier (Nexstim
Ltd., Helsinki, Finland) was used to record artifact-free
electrical brain responses to single TMS pulses (Virtanen
et al. 1999). On average, 247 ± 11 (mean ± standard
error) pulses were delivered in each session (range 199–
332 pulses). Impedance at all electrodes was kept below
5 kX. EEG signals were band-pass filtered between 0.1 and
500 Hz and sampled at 1,450 Hz with 16 bit resolution. In
order to monitor ocular movements and blinks, vertical
electrooculogram was recorded with two extra sensors. The
position of EEG electrodes on the scalp was digitized and
provided to the NBS system for integration with individual
MR images and for allowing a precise replacement of the
EEG cap between sessions.
Table 2 Clinical and neurophysiological effects of ECT
Patient n ECT
sessions
HDRS IRA (lV2) IRS (lV/ms)
Pre-ECT Post-ECT p Pre-ECT Post-ECT p Pre-ECT Post-ECT p
1 8 38 18 47 58 .034 0.57 0.80 .006
2 7 27 13 74 82 .014 0.76 1.07 .000
3 3 22 3 57 75 .020 0.64 0.67 .771
4 8 20 12 9 18 .026 0.04 0.46 .004
5 7 25 16 132 196 .002 0.21 0.52 .000
6 9 19 12 14 23 .010 0.09 0.14 .268
7 5 25 2 9 21 .002 0.15 0.31 .000
8 3 19 3 24 33 .024 0.36 0.37 .717
Mean ± SE 6.3 ± 0.82 24.4 ± 2.22 9.9 ± 2.23 .025 45.7 ± 14.94 63.2 ± 20.90 .025 0.35 ± 0.1 0.54 ± 0.11 .025
SE standard error, ECT electroconvulsive therapy, HDRS Hamilton Depression Rating Scale, IRA immediate response area, IRS immediate
response slope
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Data Analysis
Data analysis was carried out using MATLAB (2006a,
The MathWorks, Natick, MA, USA). Principal Component
Analysis was applied to automatically reduce ocular arti-
facts (Casarotto et al. 2004). Single TEPs residually con-
taminated by muscular activity (absolute power of EEG
channel F8 above 25 Hz [ 0.9 lV2/Hz) (van de Velde
et al. 1998) were automatically rejected. After averaging a
minimum of 90 artifact-free trials (mean ± standard error
across sessions: 127 ± 10 trials; range 90–189 trials),
channels containing high-frequency muscular activity or
large residual artifacts were excluded from further analysis.
Bad channels (always fewer than ten) were usually con-
taminated by high-frequency muscular activity and were
mostly located peripherally over fronto-temporal muscles.
Signal quality of channels nearby the stimulated site was
always acceptable. In order to apply data analysis to the
same number of channels across sessions and patients, we
have interpolated bad channels using ‘‘Matlab 4 griddata
method’’ (Sandwell 1987). Artifact-free signals were band-
pass filtered between 2 and 80 Hz, down-sampled to
725 Hz, and re-referenced to the common average
reference.
We measured cortical excitability from the immediate
EEG response to TMS. In all patients, TMS triggered a
large, early TEP component, consisting in a positive wave
(Fig. 1a, white reversed U-shaped trace) followed by a
negative wave (Fig. 1a, white U-shaped trace) and with
maximum amplitude in the electrode overlying the TMS
target. We selected for each patient the six neighboring
EEG channels (region-of-interest (ROI)) where this com-
ponent had the largest amplitude (Fig. 1a, black traces) and
we quantified two morphological features of this compo-
nent, the immediate response area (IRA) and slope (IRS).
IRA was obtained from the local mean field power (LMFP)
of the TEPs across the ROI channels (computed as the
square root of squared TEPs averaged across the ROI
Fig. 1 Computation of cortical excitability in patient 1. a Lateral
plots represent the average TEPs superimposed in all EEG channels
before (pre-) and after (post-) ECT. Central map depicts the
electrodes arrangement (black and gray dots) on the scalp. Black
traces correspond to ROI channels, located nearby the stimulated site
(black cross) and containing a large, early TEP component, consisting
in a positive wave (white reversed U-shaped trace) followed by a
negative wave (white U-shaped trace). b LMFP of the ROI channels.
Cortical excitability was measured by the subtended area (dark gray
shadow) between the two local minima (light gray shadow) encom-
passing the early consecutive positive and negative waves triggered
by TMS (IRA). c TEPs averaged across the ROI channels in the two
conditions. Slanting lines highlight the slope of the rising side of the
large positive wave early evoked by TMS (IRS)
330 Brain Topogr (2013) 26:326–337
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channels; Fig. 1b) (Lehmann and Skrandies 1980): in
particular, we detected the two local minima encompassing
the early consecutive positive and negative evoked waves
(light gray shadow, Fig. 1), and then we calculated the
integral of the LMFP within this interval (dark gray sha-
dow, Fig. 1b). Since TEPs were highly reproducible across
sessions, we used the same time interval in both pre- and
post-ECT sessions. IRS was computed on single-trial TEPs
averaged in space across the ROI channels: specifically, it
was defined as the mean first derivative of the rising side of
the positive wave (Vyazovskiy et al. 2008) of the early
TMS-evoked component (Fig. 1c). Identification of the
ROI channels, of the early TMS-evoked component, and of
the local minima of the LMFP was performed for each
patient separately with a computerized procedure and was
then verified manually.
In order to study the effects of ECT at the group level,
we applied a non-parametric paired sign test to compare the
HDRS score, IRA, and IRS values between pre- and post-
ECT sessions across patients. In addition, IRA and IRS
values were statistically compared between sessions at the
single-subject level. In the case of IRA, we applied the
following non-parametric permutation-based statistical
analysis: (i) under the null hypothesis of equivalence
between pre- and post-ECT recordings, 1000 ‘‘mixed’’
TEPs were constructed by averaging single trials randomly
selected from the two sessions; (ii) LMFP was computed
from these surrogate TEPs and was used to estimate the
empirical null distribution of IRA; (iii) cortical excitability
in each patient was considered significantly affected by
ECT with probability of false positives a when the actual
IRA values laid beyond the a-th percentile tails of the null
distribution. IRS was compared between sessions by non-
parametric Wilcoxon rank sum test applied to single-trial
slope values in each patient.
Results
At the group level, the clinical effect of ECT was a sig-
nificant reduction of the HDRS score (p \ .025) as com-
pared to baseline values (Table 2, Fig. 2a left panel). TEPs
displayed similar morphology across patients and were
characterized by an early evoked component consisting of
a positive wave between 13 ± 2 and 27 ± 5 ms followed
by a negative wave peaking at about 47 ± 5 ms; the grand
average TEP across patients (Fig. 2a right panel) shows
that the amplitude of this component was clearly increased
after ECT. IRA and IRS values were significantly increased
at the group level after ECT (Table 2). Moreover, the
increase of IRA after ECT as compared to baseline was
significantly correlated with the corresponding increase of
IRS (Pearson’s correlation = .86, R2 = .70, p \ .006).
Statistical analysis further confirmed that the modulation
of cortical excitability brought about by ECT was signifi-
cant at the single-subject level (Fig. 2; Supplementary
Fig. 2S). Fig. 2b displays the time course of individual
TEPs and LMFP within the ROI channels. The morphology
of the immediate EEG response to TMS was generally
comparable among individuals and was highly reproduc-
ible between pre- and post-ECT sessions in the same
patient. Most important, in all patients we observed an
increase of the consecutive positive and negative waves
early evoked by TMS and a corresponding increase of the
LMFP after ECT. Non-parametric statistical comparison
between pre- and post-ECT sessions showed that IRA was
significantly increased in each and every patient (Table 2;
Fig. 2c), while IRS increase was significant in all but 3
patients (Table 2; Fig. 2d; patients 3, 6, 8).
At the group level, the percentage reduction of HDRS
by treatment was inversely correlated with the number of
ECT sessions (Pearson’s correlation = -.89, R2 = .75,
p \ .004), indicating that mood improved more in patients
with a faster response to ECT. A positive trend was
observed between the percentage reduction of HDRS in
post-ECT compared to pre-ECT session and the corre-
sponding percentage increase of IRA, although correlation
was not statistically significant (Pearson’s correlation =
.53, R2 = .28, p \ .18).
Discussion
This study provides the first experimental evidence that
ECT increases frontal cortex excitability in patients
affected by severe major depression. This result was
obtained by measuring the immediate (early and local)
EEG response to a direct perturbation with navigated TMS.
Previous attempts to measure cortical excitability during
a course of ECT were performed on the peripheral motor
evoked potentials (electromyogram (EMG)) induced by
TMS of the primary motor cortex (Sommer et al. 2002;
Chistyakov et al. 2005; Bajbouj et al. 2005, 2006). While
single-case studies (Sommer et al. 2002; Bajbouj et al.
Fig. 2 a (Left) At the group level, the HDRS assessed after (gray
bar) ECT was significantly smaller (p \ .025) than before treatment
(black bar). (Right) Superimposition of grand average TEPs collected
before (black trace) and after (gray trace) ECT. b Individual time
courses of the TEPs averaged across ROI channels and of the LMFP
of ROI channels before (black traces) and after (gray traces) ECT.
c Single-subject comparisons (using permutation-based statistics)
between cortical excitability, as measured by the IRA, before (black
bars) and after (gray bars) ECT. d Single-subject comparisons
(Wilcoxon rank sum test) between the IRS before (black bars) and
after (gray bars) ECT. See Materials and Methods section for the
individual selection of ROI channels and definition of IRA and IRS.
*p \ .05; **p \ .005
c
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2005) showed a reduction of cortical excitability after ECT
(increase of intracortical inhibition, cortical silent period
duration, and resting motor threshold), group results
(Chistyakov et al. 2005) indicated an increase of cortical
excitability as reflected by reduced motor threshold and
intracortical inhibition. In the present study, we stimulated
the frontal cortex, which is mostly involved by ECT effects
(Boylan et al. 2001; Lee et al. 2012), and we analyzed the
local EEG responses immediately triggered in this area by
TMS. Notably, the TMS/EEG approach proposed here
provides a direct measure of cortical excitability that is
complementary to the TMS/EMG approach, because it
by-passes spinal motorneurons and because it is applicable
outside the motor cortex.
Developing TMS/EEG as a clinical tool for monitoring
plastic/excitability changes in cortical circuits requires an
adequate protocol for recording and analyzing data. The
TMS/EEG apparatus used in this work was equipped with a
neuronavigation system and took into account individual
anatomical variability (Ruohonen and Karhu 2010). Previ-
ous works have shown that TMS-evoked responses recorded
several days/weeks apart under the same experimental
conditions are statistically identical (Lioumis et al. 2009;
Casarotto et al. 2010): therefore, the significant TEP changes
we observed in the same patient between pre- and post-ECT
sessions cannot be ascribable to unknown experimental
variables or measurement uncertainty, but are actually due
to significant changes in neural responsiveness. The reli-
ability of TEPs is strictly contingent on the use of neuro-
navigation, which ensures a reproducible targeting across
sessions. Hence, MR-guided navigated stimulation may be
an important requirement for the application of TMS/EEG
as a clinical monitoring tool.
We found that the early response of frontal cortical neu-
rons to a direct stimulation was significantly larger after a
course of ECT treatment as compared to baseline. This result
was observed in a rather limited population of patients;
however, the effect was strong and consistent, since IRA
increase was statistically significant in each and every
patient. Whether this increase in cortical excitability reflects
synaptic potentiation as suggested by animal models of ECT
(Stewart et al. 1994; Nibuya et al. 1995; Altar et al. 2004)
remains an open question. Indeed, the complex relationship
between depression and neuroplasticity clearly involves
multiple signaling cascades that regulate neuronal activity,
including inhibitory neurotransmitters (Sackeim 2004),
besides the glutamatergic system (Sanacora et al. 2008;
Biedermann et al. 2011). Nonetheless, the possible
involvement of neuroplasticity processes might be sup-
ported by the observation that also the slope of early TEPs
was increased. Indeed, in the animal model, changes in slope
of the first local field potential component elicited by elec-
trical stimulation of cortical axons reflect changes in
excitability related to the strengthening or weakening of
cortical synapses. Accordingly, in vivo long-term potentia-
tion-inducing procedures increase the local field potential
slope (Bliss and Lomo 1973; Stewart et al. 1994), whereas
long-term depression-inducing procedures reduce it
(Kirkwood et al. 1993). Actually, IRS increase was signifi-
cant in most, but not all, of the patients: however, it is
challenging to properly record the local and immediate
neuronal response to TMS, due to unwanted activation of
cranial muscles nearby the stimulated site. Therefore,
although we succeeded in recording good-quality early
TEPs from most patients, IRA might be an alternative, more
reliable measure of cortical excitability with respect to IRS
in a clinical context. Nonetheless, finding a significant
increase of IRS at the single-subject level in most patients
further supports the possible interpretation of increased
cortical excitability in terms of neuroplasticity processes.
Previous studies have related the neurobiological sub-
strates of depression to an inter-hemispheric imbalance
(Davidson and Irwin 1999; Maeda et al. 2000; Hecht 2010):
indeed, emotions seem to be differently processed in the left
and right hemisphere (Grimm et al. 2006) and cerebral blood
flow and metabolism at rest have been observed to be
abnormally reduced in the left prefrontal cortex and abnor-
mally increased in the right prefrontal cortex in major
depressed patients as compared to healthy subjects (Mayberg
2003). Moreover, therapeutic repetitive TMS is clinically
delivered at a high-frequency rate over the left hemisphere
(to increase cortical activity) and at a low-frequency rate
over the right hemisphere (to suppress cortical activity)
(Fitzgerald et al. 2003; Gershon et al. 2003). As a conse-
quence, it is possible that the mechanism of action of any
antidepressant treatment could be in principle affected by
this asymmetry. The present study was not intended to spe-
cifically investigate the electrophysiological effects of ECT
in the left and right hemisphere separately: rather, TMS
pulses were delivered on the scalp nearby the mid-sagittal
plane, slightly on the left side of the head in half of the
patients and slightly on the right side in the other half (see
TMS/EEG recording paragraph and Supplementary
Fig. 1S). Basically, we stimulated mainly one hemisphere in
a region close to the midline and we involved, to a lesser
extent, also the contralateral hemisphere. The possibility that
we actually obtained a direct stimulation of both hemi-
spheres is supported by observing that the induced EF
peaking at 90–130 V/m in the TMS target area actually
activated above threshold a cortical area of several cm2, as
estimated by the navigation system, and that the ROI chan-
nels with the largest early TMS-evoked EEG response were
usually located bilaterally (Supplementary Fig. 1S). In two
patients we were able to record EEG responses to stimula-
tion of both hemispheres: results revealed a significant
increase of both IRA and IRS in each patient bilaterally
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(Supplementary Fig. 2S). These observations confirm that
ECT induces a comparable increase of cortical excitability
on both sides of the brain, as could be expected by the
bilateral electrode placement used in this therapeutic proto-
col. Clearly, most of the patients were prevalently stimulated
on one hemisphere and therefore we could have missed the
observation of a possible cortical excitability imbalance at
baseline. This issue should be considered in future studies on
larger sample size by comparing the immediate EEG
response to TMS of the left and right hemisphere in the same
patients.
The present results, showing increased frontal cortical
excitability after ECT, fit with the observation that while
stress reduces the expression of BDNF in the hippocampus
and frontal cortex, antidepressants produce the opposite
effect and promote neurons/glia survival and growth (Manji
et al. 2001; Dwivedi et al. 2003; Salvadore et al. 2011;
Duman and Voleti 2012). Accordingly, ECT increases neu-
rotrophins, e.g. BDNF (Nibuya et al. 1995; Altar et al. 2004)
and synaptic efficacy (Stewart et al. 1994), and BDNF/TrkB
potentiate cortical excitability through interaction with glu-
tamate and its receptors (Mamounas et al. 1995; Mattson
2008; Minichiello 2009). In humans, the glutamate/gluta-
mine levels as measured by proton MR spectroscopy have
been reported to be significantly smaller at baseline in
depressed patients as compared to healthy subjects and to
increase after successful ECT (Michael et al. 2003).
We observed a positive, yet not significant, trend
between IRA increase and mood improvement as measured
by HDRS. Although we do not aim to convey any prog-
nostic information due to our limited sample size, we
propose to further investigate the relationship between
clinical and electrophysiological measurements of neuro-
modulatory treatments on larger populations, possibly
accounting for confounding factors, e.g. gender, disease
severity, or social influences.
A limitation of the present study consists in the lack of a
control group, i.e. a comparable group of depressed
patients treated with ‘‘sham’’ ECT, due to ethical reasons
and to the limited number of available patients. Previous
studies have necessarily applied a classical randomized
placebo-controlled design to demonstrate the therapeutic
efficacy of ECT (Freeman et al. 1978; West 1981). How-
ever, we took for granted the general antidepressant effects
of ECT and we specifically focused on the electrophysio-
logical modifications induced by this neuromodulatory
treatment in frontal cortical circuits. Therefore, for our
purposes it was unethical to preclude severely depressed
patients at high risk from receiving a generally effective
treatment and, at the same time, to submit them to a dose of
anesthetic. Since we observed a significant increase of
cortical excitability after ECT in each and every patient,
despite the reduced sample size, we believe it is very
unlikely that an unknown and uncontrollable variable other
than ECT would have been able to significantly modulate
TEPs consistently across patients. This study showed a
clear-cut neurophysiological effect of ECT on cortical
excitability, that could be detected statistically at the sin-
gle-subject level: therefore, it suggests that a new tool
based on TMS/EEG could be available to guide and
monitor different antidepressant treatments. Clearly, ECT
engenders a coarse effect on brain circuits. Thus, it would
be interesting to employ TMS/EEG study the effects of
more refined neuromodulatory treatments, e.g. repetitive
TMS (O’Reardon et al. 2007; Padberg and George 2009;
Slotema et al. 2010). rTMS is a non-convulsive mean to
induce neuromodulation that does not require anesthesia,
and has negligible side effects compared to ECT. In
addition, the local activation of prefrontal cortical circuits
by rTMS has been shown to indirectly affect subcortical
regions involved in mood regulation (Li et al. 2004). Still,
the antidepressant effects of rTMS are weaker as compared
to ECT (Knapp et al. 2008) and can be unpredictable at the
single-patient level (Hasey 2001; Eranti et al. 2007), pos-
sibly because of inadequate optimization of stimulation
parameters, e.g. frequency, intensity, targeting (Hasey
2001; Lam et al. 2008). To the extent that an increase of
frontal cortex excitability is the desired electrophysiologi-
cal effect of antidepressant treatment, TMS/EEG measures
may represent a reliable tool to quantify objectively and
optimize therapeutic neuromodulation and may be used to
identify effective stimulation parameters on an individual
basis. For example, IRA can be calculated automatically
from a small subset of electrodes nearby the TMS target
and is able to detect significant effects at the single-subject
level. Therefore, simpler experimental set-ups could be
developed to study the effects of different treatments in
larger cohorts of depressed patients. In future studies TMS/
EEG set-ups may be used to evaluate the effects of other
treatments, such as sleep deprivation, rTMS, and trans-
cranial direct current stimulation.
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